Identifying an important drug interaction

Using Clinical Decision Support to improve patient outcomes and hospital performance

Friday, May 13, 2011 by Chris Madjerich
As hospitals and EMR vendors scramble to prepare for Stage I Meaningful Use criteria, the Stage II criteria are already being prepared.  The Stage II requirements will require hospitals to continue with and advance the use of CPOE, and the use of clinical decision support elements including drug interaction and drug allergy screening.  Additionally, patient education materials must be offered to at least 80% of patients at discharge.

Although most of these requirements are simply advancing a requirement from Stage I, the ultimate goal of requiring the use of clinical decision support tools is to improve patient care, especially as it relates to high priority health conditions.  In order to accomplish this, CDS should have specific attributes:  authenticated, credible, evidenced-based and patient-context sensitive.  This can only be accomplished by using a drug reference database that can provide information that meets this criteria. 

Lexicomp provides clinical information that can be used to perform key CDS functions such as drug interaction, drug allergy, duplicate therapy and dosage range screening.  This content is derived from our well established drug reference information that is evidenced-based, peer-reviewed and up-to-date.  If you are a clinician working in health care, you most likely have relied on this content to help you make patient care decisions for many years.  If CDS is going to accomplish its goal of improving patient care, it is going to require a strong, evidenced based library of clinical information.  Something Lexicomp has been doing for over 30 years.

Comments for Using Clinical Decision Support to improve patient outcomes and hospital performance

Leave a comment





Captcha